Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.
Petrucci
Maria Teresa
MT
Martini
Vincenza
V
Levi
Anna
A
Gallucci
Cristiano
C
Palumbo
Giovanna
G
Del Bianco
Patrizia
P
Torromeo
Concetta
C
Foà
Robin
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D016879:Salvage Therapy; D016019:Survival Analysis; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide